Chronic kidney disease trials in Czechia

In Czechia 16 Also abroad 798

16 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 12 November 2026. Ask the study team whether a trial fits you.

Phase 3Taking people
"AMBITION 2: A research study investigating how well zenagamtide lowers blood sugar and body weight compared to placebo in people with type 2 diabetes and chronic kidney disease treated with once daily basal insulin alone or in combination with metformin, SGLT2i, or both."
Where
Chrudim, Prague, Prague 4, Prague 9
Age
18 years and over
People
95 worldwide
Run by
Novo Nordisk A/S
See details and how to join2026-525471-13-00 · EU 2026-525471-13-00
Phase 3Taking people
A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure
Where
Brandys nad Labem, Brandýs nad Labem, Frýdek-Místek, Jilemnice, Krnov, Mlada Boleslav, Náchod, Olomouc, Plzen 1, Prague, Prague 6, Praha 10, Slaný
Age
18 years and over
People
5,000 worldwide
Run by
AstraZeneca
See details and how to joinNCT06742723 · EU 2023-506460-14-00
Phase 3Taking people
A Study of Orforglipron (LY3502970) on Cardiovascular Outcomes in Adults With Atherosclerotic Cardiovascular Disease and/or Chronic Kidney Disease (ATTAIN-Outcomes)
Where
Brandýs nad Labem, České Budějovice, Chlumec Nad Cidlinou Iv, Havířov, Jilove U Prahy, Krnov, Ostrava, Poštovní, Prague, Praha 1, Praha 6
Age
50 years and over
People
7,140 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT07241390 · EU 2025-523123-22-00
No phaseEnrolling by invitation
Assessment of Worldwide Acute Kidney Injury Epidemiology in Neonates 2.0
Where
Prague
Age
0 Minutes to 2 weeks
People
8,000 worldwide
Run by
Indiana University
See details and how to joinNCT06823115
Phase 3Taking people
A Rollover Extension Program (REP) to Evaluate the Long-term Safety and Tolerability of Open Label Iptacopan/LNP023 in Participants With Primary IgA Nephropathy
Where
Prague
Age
18 years to 100 years
People
540 worldwide
Run by
Novartis Pharmaceuticals
See details and how to joinNCT04557462 · EU 2023-508690-92-00
Phase 3Taking people
A Study to Learn More About How Safe the Study Treatment Finerenone is in Long-term Use When Taken With an ACE Inhibitor or Angiotensin Receptor Blocker Over 18 Months of Use in Children and Young Adults From 1 to 18 Years of Age With Chronic Kidney Disease and Proteinuria
Where
Prague, Prague 2
Age
1 year to 18 years
People
100 worldwide
Run by
Bayer
See details and how to joinNCT05457283 · EU 2023-504885-50-00
Phase 2/3Taking people
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
Where
Český Krumlov, Hradec Králové, Nový Jičín, Ostrava, Prague
Age
18 years and over
People
3,110 worldwide
Run by
CSL Behring
See details and how to joinNCT05485961 · EU 2022-500273-14-00
Phase 3Taking people
Efepoetin alfa for treatment of anemia in chronic kidney disease on dialysis
Where
Havlickuv Brod, Horni Brana, Plzen 1, Teplice
Age
18 years and over
People
337 worldwide
Run by
Genexine Inc.
See details and how to join2023-503634-50-01 · EU 2023-503634-50-01
Phase 3Taking people
A Study to Investigate Outcomes With Elecoglipron Compared With Placebo in Adult Participants With Chronic Kidney Disease.
Where
Hradec Králové, Humpolec, Jejkov, Jilemnice, Liberec (Neclenene Mesto), Marianske Lazne, Náchod, Nove Mesto Na Morave, Nový Jičín, Ostrava, Prague, Prague 3, Prague 6, Tábor
Age
18 years and over
People
7,000 worldwide
Run by
AstraZeneca
See details and how to joinNCT07753993 · EU 2025-523994-41-00
Phase 3Taking people
A Phase 3 Study of Etelcalcetide in Children With Secondary Hyperparathyroidism Receiving Hemodialysis
Where
Prague 5
Age
2 years to 17 years
People
24 worldwide
Run by
Amgen
See details and how to joinNCT03969329 · EU 2023-506471-10-00
Phase 3Taking people
A Phase 3 Study of Efepoetin Alfa for Treatment of Anemia in Patients With Chronic Kidney Disease on Dialysis
Where
Český Krumlov, Havlíčkův Brod, Pilsen, Teplice
Age
18 years and over
People
429 worldwide
Run by
Genexine, Inc.
See details and how to joinNCT06466785
No phaseTaking people
International (Pediatric) Peritoneal Biobank
Where
Prague
Age
1 day to 90 years
People
500 worldwide
Run by
Heidelberg University
See details and how to joinNCT01893710
Phase 2Taking people
A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease
Where
Český Krumlov, Frýdek-Místek, Hodonín, Prague, Smiřice
Age
18 years and over
People
465 worldwide
Run by
Novo Nordisk A/S
See details and how to joinNCT06717698 · EU 2024-510846-15-00
No phaseTaking people
Comparison of Individualized Sodium Management Versus Standard Treatment in Hemodialysis
Where
Mariánské Lázně
Age
18 years and over
People
130
Run by
Fresenius Medical Care Deutschland GmbH
See details and how to joinNCT06341452
No phaseTaking people
Chronic Kidney Disease Screening
Where
Prague
Age
18 years and over
People
3,000
Run by
Institute for Clinical and Experimental Medicine
See details and how to joinNCT07153432
No phaseTaking people
Fetuin A as a Predictor of Deterioration of Renal Function in Hypertonic Patients
Where
Ostrava
Age
18 years to 100 years
People
200
Run by
University Hospital Ostrava
See details and how to joinNCT05963126